165
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Validation of modified World Health Organization classification for pregnant women with heart disease in a tertiary care center in southern Thailand

, , &
Pages 47-53 | Published online: 18 Jan 2018
 

Abstract

Purpose

To validate the modified World Health Organization (WHO) classification in pregnant women with congenital and acquired heart diseases.

Patients and methods

The database of pregnant women with heart disease, who delivered at Songklanagarind Hospital between January 1995 and December 2016, was retrieved from the Statistical Unit, Department of Obstetrics and Gynecology, along with the Hospital Information System of Songklanagarind Hospital, Faculty of Medicine, Prince of Songkla University. Each patient was retrospectively classified according to the modified WHO classification of maternal cardiovascular risk. Comparison of maternal and fetal outcomes among the modified WHO classes were analyzed using the chi-square test or Fisher’s exact test and one-way ANOVA test. A p-value of <0.05 was considered statistically significant.

Results

A total of 331 cases were studied: 157 cases with congenital heart disease and 174 cases with acquired heart disease. There were 48, 173, 32 and 78 cases in the modified WHO class I, II, III and IV, respectively. Congestive heart failure was the most common complication. The overall maternal mortality rate was 3.6%, all of which were in the modified WHO class IV. Maternal cardiovascular events occurred in 24.2% of cases, increasing rates with higher modified WHO class: 4.2%, 15.0%, 25.0% and 56.4% in class I, II, III and IV, respectively (p<0.001). Adverse fetal outcomes including preterm delivery, low birth weight, small for gestational age and neonatal intensive care unit admission were also significantly increased in class III and IV (p<0.05).

Conclusion

The modified WHO classification is useful not only for obtaining a cardiovascular risk assessment in pregnant women with heart disease but also for predicting adverse fetal outcomes. It must, therefore, be implemented into routine care service at all levels of health care systems.

Acknowledgments

This study was supported by a grant from the Faculty of Medicine, Prince of Songkla University. The abstract of this paper was presented at the 25th Asian & Oceanic Congress of Obstetrics and Gynecology 2017 as an E-poster presentation with interim findings. The poster’s abstract was published in “Poster Abstracts” in the Journal of Obstetrics and Gynaecology Research, Volume 43, Issue Supplement S1, June 2017 (http://onlinelibrary.wiley.com/doi/10.1111/jog.13388/full).

Disclosure

The authors report no conflicts of interest in this work.